BMD4503-1

Overview

BMD4503-1 is a quinoxaline derivative. BMD4503-1 can inhibit the LRP5/6 - Sclerostin interaction and regulate the Wnt signaling pathway.

Application

Products | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Others | Products > Signaling Pathways > Wnt

Product Information

• Catalog No.: HY-169508
• CAS No.: 301357-76-6
• Molecular Formula: C22H19N5O3S
• Molecular Weight: 433.48
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source